BiotechTube
Home/Opthea/Dr. Megan Baldwin
DM

Dr. Megan Baldwin

Chief Executive Officer & Managing Director

Opthea

Therapeutic Areas

OphthalmologyRetinal Diseases

Opthea Pipeline

DrugIndicationPhase
Sozinibercept (OPT-302)Wet Age-Related Macular Degeneration (Wet AMD)Phase 3

Leadership Team at Opthea

MF
Mr. Fredrik Wiklund
Chief Financial Officer & Company Secretary
DC
Dr. Celia Fung
Vice President, Clinical Development
DP
Dr. Pravin Dugel
Consulting Medical Director
MJ
Mr. Jeremy Curnock Cook
Non-Executive Chairman
PD
Prof. David Calcott
Non-Executive Director
MC
Ms. Christine Chow
Non-Executive Director
DS
Dr. Sherryl Robertson
Non-Executive Director
DA
Dr. Andrew Nash
Chief Scientific Officer
PP
Prof. Peter Campochiaro
Scientific Advisory Board Member
PD
Prof. David Charteris
Scientific Advisory Board Member
View full Opthea profile